To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
Biosecurity Program, The Kirby Institute, University of New South Wales (UNSW), 2052, Sydney, Australia; Programme on Emerging Infections, Infectious Diseases Division, Dhaka, Bangladesh .
Biosecurity Program, The Kirby Institute, University of New South Wales (UNSW), 2052, Sydney Australia.
Biosecurity Program, The Kirby Institute, University of New South Wales (UNSW), 2052, Sydney Australia.
Department of Cardiology, Blacktown Hospital, University of Western Sydney, 2148, Blacktown, NSW, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, 2052, Sydney, NSW, Australia; Department of Cardiology, Westmead Hospital, Sydney University, 2145, Westmead, NSW, Australia.
Show others and affiliations
2023 (English)In: European Heart Journal, Supplement, ISSN 1520-765X, E-ISSN 1554-2815, Vol. 25, no Suppl A., p. A42-A49Article, review/survey (Refereed) Published
Abstract [en]

COVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or pericarditis. Patients with COVID-19 may present with non-specific symptoms that have a cardiac origin. This review examines the cardiovascular complications of COVID-19 infection and the impact of COVID-19 vaccination. COVID-19 cardiovascular complications include myocardial injury, pericarditis, coagulopathy, myocardial infarction, heart failure, arrhythmias, and persistent post-acute risk of adverse cardiovascular outcomes. Diagnostic and referral pathways for non-specific symptoms, such as dyspnoea and fatigue, remain unclear. COVID-19 vaccination is cardioprotective overall but is associated with myopericarditis in young males, though at a lower rate than following SARS-CoV-2 infection. Increased awareness among primary care physicians of potential cardiovascular causes of non-specific post-COVID-19 symptoms, including in younger adults, such as fatigue, dyspnoea, and chest pain, is essential. We recommend full vaccination with scheduled booster doses, optimal management of cardiovascular risk factors, rapid treatment of COVID-19, and clear diagnostic, referral, and management pathways for patients presenting with non-specific symptoms to rule out cardiac complications.

Place, publisher, year, edition, pages
Oxford University Press, 2023. Vol. 25, no Suppl A., p. A42-A49
Keywords [en]
COVID-19, Cardiovascular, Heart, SARS-CoV-2, Vaccines
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:oru:diva-105103DOI: 10.1093/eurheartjsupp/suac123ISI: 000944157600008PubMedID: 36937372Scopus ID: 2-s2.0-85154549435OAI: oai:DiVA.org:oru-105103DiVA, id: diva2:1744839
Available from: 2023-03-21 Created: 2023-03-21 Last updated: 2024-01-16Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Fröbert, Ole

Search in DiVA

By author/editor
Fröbert, Ole
By organisation
School of Medical Sciences
In the same journal
European Heart Journal, Supplement
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 142 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf